MicroRNA-374a Expression as a Prognostic Biomarker in Lung Adenocarcinoma
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Lung cancer is the most common cause of cancer-related death, and adenocarcinoma is the most common histologic subtype. MicroRNA is a small non-coding RNA that inhibits multiple target gene expression at the post-transcriptional level and is commonly dysregulated in malignant tumors. The purpose of this study was to analyze the expression of microRNA-374a (miR-374a) in lung adenocarcinoma and correlate its expression with various clinicopathological characteristics. Methods: The expression level of miR-374a was measured in 111 formalin-fixed paraffin-embedded lung adenocarcinoma tissues using reverse transcription-quantitative polymerase chain reaction assays. The correlation between miR-374a expression and clinicopathological parameters, including clinical outcome, was further analyzed. Results: High miR-374 expression was correlated with advanced pT category (chi-square test, p = .004) and pleural invasion (chi-square test, p = .034). Survival analysis revealed that patients with high miR-374a expression had significantly shorter disease-free survival relative to those with low miR-374a expression (log-rank test, p = .032). Conclusions: miR-374a expression may serve as a potential prognostic biomarker for predicting recurrence in early stage lung adenocarcinoma after curative surgery.
Abstract
Background: Lung cancer is the most common cause of cancer-related death, and adenocarcinoma is the most common histologic subtype. MicroRNA is a small non-coding RNA that inhibits multiple target gene expression at the post-transcriptional level and is commonly dysregulated in malignant tumors. The purpose of this study was to analyze the expression of microRNA-374a (miR-374a) in lung adenocarcinoma and correlate its expression with various clinicopathological characteristics. Methods: The expression level of miR-374a was measured in 111 formalin-fixed paraffin-embedded lung adenocarcinoma tissues using reverse transcription-quantitative polymerase chain reaction assays. The correlation between miR-374a expression and clinicopathological parameters, including clinical outcome, was further analyzed. Results: High miR-374 expression was correlated with advanced pT category (chi-square test, p = .004) and pleural invasion (chi-square test, p = .034). Survival analysis revealed that patients with high miR-374a expression had significantly shorter disease-free survival relative to those with low miR-374a expression (log-rank test, p = .032). Conclusions: miR-374a expression may serve as a potential prognostic biomarker for predicting recurrence in early stage lung adenocarcinoma after curative surgery.
참고문헌 (28)
- Cronin KA, "Annual report to the nation on the status of cancer, part I : national cancer statistics", Cancer, 124, pp.2785~2800 (2018)
- 김호철, "Clinical Characteristics and Prognostic Factors of Lung Cancer in Korea: A Pilot Study of Data from the Korean Nationwide Lung Cancer Registry", Tuberculosis and Respiratory Diseases, 82(2), pp.118~125 (2019), 대한결핵및호흡기학회[DOI]
- Chen K, "The evolution of gene regulation by transcription factors and microRNAs", Nat Rev Genet, 8, pp.93~103 (2007)
- Bartel DP, "MicroRNAs : genomics, biogenesis, mechanism, and function", Cell, 116, pp.281~297 (2004)
- Calin GA, "MicroRNA signatures in human cancers", Nat Rev Cancer, 6, pp.857~866 (2006)
- Trang P, "MicroRNAs as potential cancer therapeutics", Oncogene, 27(Suppl 2), pp.S52~S57 (2008)
- Lu T, "MiR-374a promotes the proliferation of osteosarcoma cell proliferation by targeting Axin2", Int J Clin Exp Pathol, 8, pp.10776~10783 (2015)
- Wang Y, "MicroRNA-374a promotes esophageal cancer cell proliferation via Axin2 suppression", Oncol Rep, 34, pp.1988~1994 (2015)
- Cai J, "MicroRNA-374a activates Wnt", β-catenin signaling to promote breast cancer metastasis, 2013, pp.123, 566~579
- Li H, "MicroRNA-374a promotes hepatocellular carcinoma cell proliferation by targeting mitogen-inducible gene 6(MIG-6)", Oncol Res, 26, pp.557~563 (2018)
- Jun Zhang, "Upregulation of miR-374a promotes tumor metastasis and progression by downregulating LACTB and predicts unfavorable prognosis in breast cancer", Cancer Medicine, 7(7), pp.3351~3362 (2018), Wiley[DOI]
- Ma L, "MicroRNA-374a promotes pancreatic cancer cell proliferation and epithelial to mesenchymal transition by targeting SRCIN1", Pathol Res Pract, 215, pp.152382~ (2019)
- Son D, "MiR-374a-5p promotes tumor progression by targeting ARRB1 in triple negative breast cancer", Cancer Lett, 454, pp.224~233 (2019)
- Chen Y, "MicroRNA-374a suppresses colon cancer progression by directly reducing CCND1 to inactivate the PI3K", AKT pathway, 2016, pp.7, 41306~41319
- Qian D, "MicroRNA-374b suppresses proliferation and promotes apoptosis in T-cell lymphoblastic lymphoma by repressing AKT1 and Wnt-16", Clin Cancer Res, 21, pp.4881~4891 (2015)
- Zhao M, "Dual roles of miR-374a by modulated c-Jun respectively targets CCND1-inducing PI3K", AKT signal and PTEN-suppressing Wnt, Cell Death Dis, pp.2018, 9[DOI]
- Hall JS, "Enhanced stability of microRNA expression facilitates classification of FFPE tumour samples exhibiting near total mRNA degradation", Br J Cancer, 107, pp.684~694 (2012)
- Zhang X, "An array-based analysis of microRNA expression comparing matched frozen and formalin-fixed paraffin-embedded human tissue samples", J Mol Diagn, 10, pp.513~519 (2008)
- Weng L, "MicroRNA profiling of clear cell renal cell carcinoma by whole-genome small RNA deep sequencing of paired frozen and formalin-fixed, paraffin-embedded tissue specimens", J Pathol, 222, pp.41~51 (2010)
- Glud M, "MicroRNA expression in melanocytic nevi : the usefulness of formalin-fixed, paraffin-embedded material for miRNA microarray profiling", J Invest Dermatol, 129, pp.1219~1224 (2009)
- Hui AB, "Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues", Lab Invest, 89, pp.597~606 (2009)
- Zheng J, "MiRNA-195-5p functions as a tumor suppressor and a predictive of poor prognosis in non-small cell lung cancer by directly targeting CIAPIN1", Pathol Oncol Res, 25, pp.1181~1190 (2019)
- Chen Y, "MiRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer", PLoS One, 12, pp.e0171751~ (2017)
- Zheng W, "MicroRNA-21 : a promising biomarker for the prognosis and diagnosis of non-small cell lung cancer", Oncol Lett, 16, pp.2777~2782 (2018)
- Wang XC, "Overexpression of miRNA-21 promotes radiation-resistance of non-small cell lung cancer", Radiat Oncol, 8, pp.146~ (2013)
- Gao W, "MiRNA-21 : a biomarker predictive for platinum-based adjuvant chemotherapy response in patients with non-small cell lung cancer", Cancer Biol Ther, 13, pp.330~340 (2012)
- He W, "MiR-374a promotes the proliferation of human osteosarcoma by downregulating FOXO1 expression", Int J Clin Exp Med, 8, pp.3482~3489 (2015)
- Zhen Y, "MiR-374a-CCND1-pPI3K", AKT-c-JUN feedback loop modulated by PDCD4 suppresses cell growth, metastasis, and sensitizes nasopharyngeal carcinoma to cisplatin, 2017, pp.36, 275~285